Cartesian Therapeutics, Inc. Common Stock

RNACNASDAQUSD
6.29 USD
0.03 (0.51%)🟢LIVE (AS OF 02:47 PM EDT)
🟢Market: OPEN
Open?$6.28
High?$6.55
Low?$6.08
Prev. Close?$6.26
Volume?56.5K
Avg. Volume?253.0K
VWAP?$6.39
Rel. Volume?0.22x
Bid / Ask
Bid?$6.26 × 100
Ask?$6.32 × 100
Spread?$0.06
Midpoint?$6.29
Valuation & Ratios
Market Cap?165.9M
Shares Out?26.5M
Float?10.2M
Float %?39.4%
P/E Ratio?N/A
P/B Ratio?-1.31
EPS?-$5.01
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.65Strong
Quick Ratio?8.65Strong
Cash Ratio?8.38Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
-1.31CHEAP
P/S?
59.33HIGH
P/FCF?
N/A
EV/EBITDA?
-0.5CHEAP
EV/Sales?
14.59HIGH
Returns & Efficiency
ROE?
105.3%STRONG
ROA?
-44.9%WEAK
Cash Flow & Enterprise
FCF?$-79395000
Enterprise Value?$40.8M
Related Companies
Loading...
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Employees
75
Market Cap
165.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698